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Abstract
Listeriosis is a leading cause of hospitalization and death due to foodborne illness in the industrialized world.
Animal models have played fundamental roles in elucidating the pathophysiology and immunology of listeriosis,
and will almost certainly continue to be integral components of the research on listeriosis. Data derived from
animal studies helped for example characterize the importance of cell-mediated immunity in controlling infection,
allowed evaluation of chemotherapeutic treatments for listeriosis, and contributed to quantitative assessments of
the public health risk associated with L. monocytogenes contaminated food commodities. Nonetheless, a number of
pivotal questions remain unresolved, including dose-response relationships, which represent essential components
of risk assessments. Newly emerging data about species-specific differences have recently raised concern about the
validity of most traditional animal models of listeriosis. However, considerable uncertainty about the best choice of
animal model remains. Here we review the available data on traditional and potential new animal models to
summarize currently recognized strengths and limitations of each model. This knowledge is instrumental for
devising future studies and for interpreting current data. We deliberately chose a historical, comparative and cross-
disciplinary approach, striving to reveal clues that may help predict the ultimate value of each animal model in
spite of incomplete data.
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1. Challenges in the study of listeriosis
Listeriosis, caused by the gram-positive, facultative intra-
cellular bacterium Listeria monocytogenes,i so n eo ft h e
leading causes of death due to foodborne illness in the
industrialized world [1,2]. Listeriosis is a relatively rare but
very serious disease, with an estimated hospitalization rate
that exceeds 90% and a mortality rate of approximately
15-30% [1,2]. In the United States, around 1600 human
cases of invasive listeriosis occur each year, resulting in
roughly 1455 hospitalizations and 255 deaths [1]. Listerio-
sis occurs almost exclusively in high-risk population sub-
groups such as pregnant women and their fetuses or
infants, the elderly, or immune compromised individuals,
but, as will be discussed below, clinical manifestations dif-
fer strongly among population subgroups [3-5].
Since volunteer feeding studies do not represent a viable
option, the current understanding of listeriosis is mainly
based on epidemiological data, clinical case reports, and
the study of animal models [2,6-9]. Animal models have
been of particular importance because listeriosis incidence
is very low and the relatively long incubation period (i.e.,
average 2 to 4 weeks) complicates the reliable identifica-
tion and characterization of food vehicles [2,6,9,10].
Optimal animal models closely resemble the respective
infection process in humans, reliably lead to the infection
endpoint of interest, allow for sufficient replicates to cap-
ture biological variability and to minimize uncertainty, and
meet economic as well as ethical constraints. To date, no
optimal animal model of listeriosis has been established
and emerging knowledge about physiological differences
among animal species has raised concerns about the direct
relevance of most animal models for human disease [11].
Listeriosis has traditionally been studied in mice, but a
variety of other species such as non-human primates, ger-
bils and guinea pigs have also occasionally been used and
these species may prove preferable to mice [12-19]. Most
studies have concentrated on pregnancy-associated disease
or neonatal infection, while studies in non-pregnant adult
animals have primarily focused on septicemia [12-19].
Geriatric models in species such as mice, rats and guinea
pigs are available and some experiments have been per-
formed in artificially immune suppressed animals, but as
will be discussed below the extrapolation to human disease
is challenging and the use of these models in the study of
listeriosis has remained limited [20,21]. For these reasons
it is largely unclear how relevant current listeriosis models
are for meningitis and hosts with predisposing factors
such as old age or immune defects.
Since the pathophysiology of infection is crucially impor-
tant for the data discussed here, we will begin our review
and discussion of animal models with a short summary of
the pathophysiology of L. monocytogenes infection. This
will be followed by a brief overview of naturally occurring
clinical listeriosis in humans and different animal species
and, after that, a discussion of the extensive literature on
animal models of listeriosis. Since many questions about
t h ep a t h o g e n i cp o t e n t i a lo fL. monocytogenes in reptiles,
amphibians, fish, crustaceans and other invertebrate species
remain and the relevance of these models for human dis-
ease therefore appears questionable [22,23], these animals
will not be explicitly discussed here even though they have
occasionally been used as models of L. monocytogenes
infection. Studies of listeriosis differ in host species and life
stage, in whether they evaluate clinical symptoms or colo-
nization of internal organs, and considerable experimental
differences complicate comparison across studies even
further. It is difficult to identify defensible, globally applic-
able and objective criteria by which to rank the scientific
merit of these highly diverse studies. We therefore provide
the reader with a comprehensive overview of the available
scientific literature, synthesizing the medical, veterinary,
immunological, microbiological and biomedical literature
pertinent to the scientific value of animal models of lister-
iosis. Where possible, we point out important experimental
details that may impact the interpretation of results, and,
recognizing the immense variability across studies, we do
n o ts t r i v et om a k ed i r e c tc o m parisons across studies.
Therefore, wherever direct comparisons are made in the
text, these are based on experiments that have been con-
ducted as part of the same study and under identical
experimental conditions if possible. We also point out
instances where multiple independent studies found con-
sistent or contradictory results. We therefore provide a
synopsis of the currently available data and the weight of
scientific evidence.
2. Pathophysiology of infections with listeria
monocytogenes
Critical evaluation of the adequacy of animal models
and comparisons across disease endpoints require a
clear understanding of the underlying pathophysiology
in humans and animals. However, numerous questions
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togenes have remained despite longstanding concerted
research efforts. The study of the pathophysiology of lis-
teriosis has been complicated by the fact that L. monocy-
togenes can enter professional phagocytic cells such as
dendritic cells through phagocytosis while direct entry
into nonprofessional phagocytic cells, for example enter-
ocytes or hepatocytes, is receptor-mediated, using caveo-
lin-dependent or clathrin-mediated endocytosis, and
dissemination within organs appears to occur mainly
through direct, actin dependent spread from cell to cell
[6,11].
The intestine is the primary port of entry for L. monocyto-
genes, but questions about the exact mechanisms by which
L. monocytogenes transgresses the intestinal barrier remain
and clear differences among host species seem to exist
(Figure 1) [6,24]. In host species deficient of functional
E-cadherin such as mice (see later sections on the discovery
of species-specific differences in the importance of inlA and
inlB for details), L. monocytogenes is thought to translocate
through the intestinal wall by gaining access into M-cells,
phagocytic cells in the Peyer’s patches of the ileum, despite
some remaining controversies about the details of this pro-
cess [24-27]. In species such as humans or guinea pigs that
possess functional E-cadherin, L. monocytogenes is on the
contrary, thought to primarily invade the epithelium of the
intestinal villi, followed by bacterial replication in the
underlying lamina propria [24,28]. L. monocytogenes then
rapidly translocates across the intestinal barrier, without a
need for bacterial replication in the intestinal wall, so that
bacteria often reach the liver and spleen within minutes of
oral inoculation [6]. However, extensive bacterial replica-
tion in the intestinal wall can occur during the intestinal
phase of infection, and in these cases bacteria appear to
move among cells of the intestinal wall via direct spread,
caused by actin polymerization that is mediated by
L. monocytogenes virulence factor ActA [6,28,29]. The
development of lasting mucosal immunity in response to
infections with L. monocytogenes is currently still subject to
debate [30]. However, in the intestinal wall, the presence of
L. monocytogenes stimulates dendritic cells, resident macro-
phages and lymphocytes, and leads to an increase in the
levels of Th1-type cytokines, NF-kB, and interleukin-15
(IL-15) [6,25,31-33]. Immune responses are therefore
clearly already elicited during the intestinal stage of
infection.
After crossing the intestinal barrier, L. monocytogenes
spreads to the liver, spleen and mesenteric lymph nodes,
probably at least partially inside infected dendritic cells
[6,24,33]. The majority of the invading bacteria become
trapped in the liver and are therefore rapidly cleared from
the circulatory system, followed by inactivation through
immune cells such as Kupffer cells, other mononuclear
phagocytic cells, neutrophils, dendritic cells and natural
killer cells even though many aspects of this process have
so far remained elusive [34,35]. Surviving bacteria replicate
in hepatocytes, but questions about the mechanisms by
which L. monocytogenes gains entry into these cells remain
[6]. In host species with functional MetC receptors such
as humans or mice (see later sections on the discovery of
species-specific differences in the importance of inlA and
inlB for details), L. monocytogenes appears to directly
invade hepatocytes, probably through the Disse space after
penetrating the endothelium that lines the liver sinusoids
[6,36-39]. In other species, for instance guinea pigs, that
do not possess functional MetC receptors, L. monocyto-
genes is thought to invade hepatocytes through cell-to-cell
spread from infected Kupffer cells [6,37]. Further dissemi-
nation of L. monocytogenes within the liver parenchyma
probably again occurs through direct, actin-mediated cell-
to-cell spread [6]. Infected hepatocytes respond to infec-
tion with L. monocytogenes by secreting chemoattractants
that recruit neutrophils to the site of infection and by initi-
ating apoptosis, resulting in the development of typical
multifocal granulomas in the liver parenchyma [6].
The remaining circulating bacteria are rapidly cleared
through resident macrophages in the spleen, even though
inactivation may be less efficient than in the liver and
extensive bacterial replication occurs in the liver and
spleen during early stages of infection [6,40]. Notably, the
spleen plays a dual role in L. monocytogenes pathophysiol-
ogy; despite initially increasing susceptibility to infection,
the spleen is indispensable for the development of subse-
quent adaptive immune responses [41]. L. monocytogenes
is initially ingested by macrophages and dendritic cells
located in the marginal zone of the spleen, followed by
translocation into the white pulp [42,43]. In the white
pulp, L. monocytogenes induces wide-spread apoptosis,
accompanied by the development of microscopic abscesses
consisting of macrophages, neutrophils and apoptotic lym-
phocytes [44]. This process appears to be required for
priming anti-Listeria cytotoxic T-cell (CTL) responses
[41]. In species that possess functional MetC receptors,
L. monocytogenes also appears to be able to enter spleno-
cytes in an inlB-dependent manner, but the precise
mechanisms have so far not been revealed [45].
If the infection is not controlled at this stage, for
instance because of severe immune suppression, a second-
ary bacteremia develops, followed by dissemination of
L. monocytogenes to a variety of secondary organs [6].
During this process L. monocytogenes can gain access
to sanctuary sites by transgressing the blood-brain barrier
or the placental barrier in pregnant hosts. Numerous
questions about the exact mechanisms by which L. mono-
cytogenes transgresses these barriers remain [6,46].
L. monocytogenes appears capable of directly invading
endothelial cells including those located in the blood-brain
barrier in an inlB-dependent manner, but in MetC
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occurs indirectly, mediated by direct cell-to-cell spread
from phagocytic cells such as macrophages [47-51].
L. monocytogenes can replicate within endothelial cells and
probably directly spreads to neighboring cells in an ActA
dependent manner [50]. While L. monocytogenes is capable
of directly invading neuronal cells, invasion of neurons in
the central nervous system is thought to predominantly
occur through direct spread from infected macrophages or
microglial cells [47]. Infected macrophages may also play a
direct role in transgressing the blood-brain barrier through
a so-called “Trojan-horse” mechanism [52]. Many ques-
tions about how L. monocytogenes transgresses the placen-
tal barrier have so far also remained unanswered, but
bacteria can probably cross the endothelium of the mater-
nal blood vessels, followed by entry into the fetal circula-
tory system of the placental villi [6]. In animal species that
possess both functional E-cadherin and MetC, this process
appears to be both InlA and InlB dependent [12]. In spe-
cies deficient in either of these receptors, however,
Figure 1 Physiological differences among laboratory animal species as well as humans and their importance in L. monocytogenes
infection.
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InlB dependent, and presumably occurs through direct
cell-to-cell spread [12,53] (see section on pregnant animal
models for further details on the impact of pregnancy on
listeriosis). Clinical listeriosis generally develops as
L. monocytogenes spreads to and invades secondary organs,
predominantly the brain and placenta.
3. Listeriosis in humans
3.1 Neonatal listeriosis and pregnancy-associated
listeriosis
Pregnancy-associated cases are thought to contribute to
between 16 and 27% of invasive listeriosis cases, and often
result in abortion, stillbirth or premature labor [54]. Since
cases of spontaneous abortion or stillbirth are not routi-
nely tested for listeriosis the fraction of fetal losses attribu-
table to listeriosis is currently unknown, but the fetal
mortality rate among women diagnosed with listeriosis is
thought to be between 16 and 45% [55]. Listerial infection
of the mother during pregnancy is often but not always
associated with infection of the fetus [56,57]. One litera-
ture review, for instance, found that 20% of reported preg-
nancy - associated cases resulted in spontaneous abortion
or stillbirth and 68% of the remaining cases (i.e., 54% of all
pregnancy-associated cases) resulted in neonatal infection,
indicating that fewer than 30% of pregnancy-associated
cases neither led to abortion or stillbirth nor to neonatal
infection [55,58]. Even though possible at any point during
pregnancy, listeriosis is most frequently reported during
the third trimester [2]. Clinical manifestations, apart from
mild flu-like prodromal symptoms, are rarely reported in
otherwise healthy women, but complications such as
meningoencephalitis or endocarditis have occasionally
been described, primarily in pregnant women with preex-
isting comorbidities [2,54,59]. Purulent villitis and micro-
abscesses are common histopathological findings in the
placentas of pregnancy-associated cases, occasionally asso-
ciated with chorioamnionitis [60]. Twin pregnancies may
potentially be associated with an increased risk of listerio-
sis, but the underlying biological determinants so far
remain largely unclear [61].
Two distinct forms of listeriosis are recognized among
neonates. Early onset disease, caused by infection in
utero, occurs during the first week of life [2]. Neonates
are often delivered pre-term, with low birth weight, and
present septicemia, pneumonia, and occasionally menin-
gitis during the first days of life [2,60,62]. Pustular skin
lesions and multifocal microabscesses in the lungs, liver
and spleen of affected infants are pathognomonic find-
ings in early onset listeriosis, causing this manifestation
to be commonly referred to as “granulomatosis infanti-
septica” [60,61]. Early onset listeriosis has a poor prog-
nosis, with a case-fatality rate of 20-30%, and surviving
infants often develop sequelae [59].
Late onset disease, on the contrary, is typically charac-
terized by meningitis, sometimes accompanied by other
symptoms such as fever, colitis and diarrhea [62]. This
manifestation generally occurs in infants 7 to 20 days after
birth [61]. In these cases, pregnancy was usually unevent-
ful, carried to term, and infants appeared healthy at birth
[59]. The source of infection often remains unclear, but
perinatal infections through contact with the birth canal,
maternal feces, or the home environment have been sug-
gested, as well as nosocomial transmissions [59,62-65].
Case-fatality rates for late onset listeriosis have been esti-
mated at approximately 10%, and neurological sequelae
have occasionally been described in surviving infants [61].
3.2 Listeriosis in adult and geriatric patients
Meningitis or meningoencephalitis and septicemia are
the most common clinical manifestations of invasive lis-
teriosis in adults and are generally associated with
comorbidities such as malignancies, immunosuppressive
therapies, alcoholism, hepatopathies, renal failure, HIV
infection, diabetes mellitus, autoimmune disorders or
hemochromatosis [61,66-68]. Septicemia occurs in an
estimated 21-43% of cases, and is often manifested as
fever, nausea, vomiting and myalgia [66]. These condi-
tions can be complicated by disseminated intravascular
coagulation, respiratory distress and multi-organ failure
[66].
Headache, nausea, high fever, stiff neck, confusion,
lethargy and less frequently ataxia, tremor and seizures are
typical clinical symptoms associated with listerial meningi-
tis or meningoencephalitis [66,68,69]. Typical histopatho-
logical findings include suppurative meningitis with
purulent exudate concentrated around the brain stem, and
white-gray foci of microabscesses in the meninges and
occasionally brain cortex [69]. In approximately 10% of
cases, L. monocytogenes affects the cortex parenchyma,
resulting in encephalitis and abscess formation which is
typically manifested as cognitive dysfunction and altered
consciousness [68]. Histological findings in the brains of
patients with listerial encephalitis include perivascular
microabscesses, multifocal vasculitis, and perivascular cuff-
ing [69]. Case - fatality rates of 15-27% have been reported
for listerial meningitis or meningoencephalitis and case-
fatality rates of up to 59% have been mentioned for
L. monocytogenes brain abscesses [67,68].
In healthy adults, listeriosis is typically manifested as
gastroenteritis, a mild, self-limiting condition characterized
by fever, diarrhea, abdominal cramps, nausea and vomit-
ing, headache, myalgia and arthralgia [2,70]. However,
rhombenchephalitis, a rare but very severe form of listerial
encephalitis, also occurs predominantly in adults without
classical comorbidities [61,71]. Rhombenchepahlitis is
characterized by a typical biphasic course - a prodromal
stage with flu-like symptoms such as fever, headache,
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onset of unilateral or bilateral paralysis of cranial nerves,
ataxia, vertigo and impaired consciousness [61,71]. Death
often occurs due to respiratory or cardiac failure, and
sequelae are common in survivors [71]. Perivascular cuff-
ing and microabscesses in cerebellum and medulla oblon-
gata are common associated histological findings [61,71].
A variety of atypical manifestations of listeriosis, invol-
ving for instance the eye, joints, bones, heart or skin
have also been documented in rare cases, and cutaneous
infections represent occupational hazards for veterinar-
ians during obstetric manipulations [55,72].
4. Naturally occuring listeriosis among domestic
and non-domestic animals
L. monocytogenes was first described by Murray et al. in
1926 who isolated the bacterium from the livers of clini-
cally sick rabbits and guinea pigs [23,73]. Since then lister-
iosis has been recognized as a disease of mammals and
birds, and as a potential zoonosis [6,74-77]. During the
1980s several large outbreaks among humans led to the
recognition of L. monocytogenes as an important food-
borne pathogen, shifting the focus from a veterinary to a
human public health problem [6,78].
4.1 Listeriosis in ruminants
Even though L. monocytogenes can infect a wide variety of
animal species, listeriosis is primarily a clinical disease of
ruminants, which can also be caused by L. ivanovii,a
Listeria species non-pathogenic for humans and other ani-
mal species [23,55]. Sheep appear to be particularly sus-
ceptible to infection, but listeriosis is also common in a
variety of other polygastric species and L. monocytogenes
has for instance been isolated from cattle, goats, llamas,
alpacas, deer, reindeer, antelopes, water buffalos and
moose [23,55,79-81]. It is worth mentioning that bacterial
shedding in the absence of clinical symptoms has occa-
sionally been observed [55,82,83].
Listeriosis represents one of the most common etiolo-
gies for encephalitis among adult ruminants [55]. Rumi-
nants affected by encephalitis generally show marked
neurological symptoms including ataxia, “circling”,
opisthotonus, and paralysis of cranial nerves, combined
with hyperthermia, anorexia and depression [84]. Ence-
phalitis is the most common clinical manifestation of lis-
teriosis in ruminants, while large epidemics of third
trimester abortions, typically manifested as stillbirth, as
well as atypical manifestations such as conjunctivitis have
also repeatedly been described [55,84,85]. With the excep-
tion of neonates and young ruminants, septicemia is unu-
sual, but can result in mastitis, gastro-enteritis, hepatitis,
or pneumonitis [55,86]. Notably, in a given affected herd
listeriosis generally exhibits a single clinical manifestation
[55,86].
Listeriosis occurs seasonally among ruminants, with the
highest incidence in winter and early spring, and appears
strongly associated with ingestion of spoiled silage
[55,87]. It has been suggested that L. monocytogenes may
cause rhombencephalitis in ruminants through centripe-
tal migration along cranial nerves, particularly the tri-
geminal nerve, followed by multiplication in pons and
medulla oblongata [6,55]. Consistent with this hypoth-
esis, changes in dentation and other lesions in the oral
cavity as well as on the lips, nostrils or conjunctiva
appear to be predisposing factors for listeriosis in rumi-
nants [55]. Typically, histopathological findings in rumi-
nants with rhombencephalitis are unilateral, located in
the brain stem, particularly pons and medulla oblongata,
and include perivascular cuffing and multifocal microabs-
cesses, generally without involvement of meninges or
choroid plexus [55,84,88]. These lesions clearly resemble
those observed in humans affected by rhombencephalitis
[88]. Septicemic cases among ruminants are character-
ized by multifocal necrosis of the liver, spleen, and poten-
tially other organs [55,84]. Placentitis and endometritis
are typical findings associated with abortions [84].
4.2 Listeriosis in monogastric mammals other than non-
human primates
Clinical listeriosis is relatively rare in most monogastric
mammals such as dogs, cats, horses and pigs, but appears
more common in rodents and lagomorpha, where listerio-
sis was first described [23,73,79]. Notably, L. monocyto-
genes has also been isolated from clinically healthy
monogastric mammals [55,82]. Listeriosis in monogastric
mammals is typically manifested as septicemia [55,89].
Abortion, meningoencephalitis and other manifestations
such as conjunctivitis are also possible, but their relative
frequency differs by animal species [55,90]. Large out-
breaks of listeriosis have been reported among colonies of
captive rodents and lagomorpha, including chinchillas,
rabbits, rats and guinea pigs [55]. Contaminated feed such
as hay or sugar beets was implicated as the outbreak vehi-
cle in many of these outbreaks, and coprophagy may have
contributed to some of the outbreaks [55]. L. monocyto-
genes has also been isolated from a variety of other rodents
and lagomorpha including gerbils, bush-tailed jirds, moun-
tain hares, European hares, Japanese hares, voles, field
mice, muskrats, shrews, capybaras, and squirrels, as well as
rock hyrax and other mammals in zoological exhibits, but
the association with clinical disease is not in all cases clear
[23,91-100]. In some of the outbreaks reported among
rodents and lagomorpha disease progression was peracute,
and death occurred prior to the development of pro-
nounced pathological lesions [55,101]. In other cases septi-
cemia and neurological symptoms such as torticollis and
ataxia dominated, even though metritis and abortion have
also been described [102,103]. For currently unknown
Hoelzer et al. Veterinary Research 2012, 43:18
http://www.veterinaryresearch.org/content/43/1/18
Page 6 of 27reasons chinchillas and rabbits appear particularly suscep-
tible to infection [73,101,103-105]. Abortion and metritis
are quite common, especially in chinchillas, and are often
associated with gastro-intestinal symptoms such as diar-
rhea, constipation, intestinal invaginations or prolapsed
rectum [104]. Common histophathological lesions include
multifocal necrosis of the liver and necrotizing endometri-
tis [94,102].
4.3 Listeriosis in non-human primates
A small number of listeriosis cases among captive non-
human primates have been described [106-108]. In addi-
tion, L. monocytogenes has been isolated from feces of wild
monkeys in Japan and Listeria from the blood of wild
baboons in Africa, but the absence or presence of clinical
symptoms in the animals was not reported and in the lat-
ter case the Listeria species was not identified [96,109].
Clinical manifestations of listeriosis as septicemia, menin-
goencephalitis and abortion have been observed in captive
non-human primates, with reported neurological symp-
toms including stiffness of the neck and paralysis of the
facial nerves [106,108,110,111]. Post-mortem examination
of a non-human primate affected by purulent meningoen-
cephalitis revealed perivascular cuffing and mononuclear
cell infiltration, while focal hepatic necrosis and placentitis
were reported in a case of perinatal septicemia, and necro-
sis of the placental villi as well as multifocal necrosis of
several fetal organs was described in a case of abortion
[107,108,110].
4.4 Listeriosis in birds
Clinical listeriosis in birds is rare, and seems to frequently
represent a secondary infection which has been associated
with a variety of viral, bacterial or parasitic diseases as well
as tumors [23,55]. Young birds are more susceptible to
disease than adult birds, and susceptibility differs among
avian species [23,76]. L. monocytogenes has been isolated
from a wide variety of domestic and wild birds including
chickens, geese, ducks, turkeys, pigeons, canaries, parrots,
eagles, owls and partridges [76]. Similar to observations in
mammals, bacterial shedding in the absence of clinical
symptoms has occasionally been described [23]. Disease in
birds is most commonly manifested as septicemia, result-
ing in focal necrosis of the liver, spleen, heart, kidneys,
lungs, air sacks, intestine, oviduct or cornea [23,76].
Listerial meningoencephalitis is uncommon among birds
[23,55]. Affected fowl exhibit typical central nervous sys-
tem symptoms including torticollis, tremor, and paralysis
of the legs or wings [23,55]. Post-mortem examination of
affected birds often reveals perivascular cuffing and focal
necrosis in the cerebellum and medulla oblongata, which
is frequently accompanied by septicemic lesions in the
liver and spleen [55].
5. Experimental infections before recognition as
foodborne disease
5.1 Experimental infections in non-pregnant animals
The first report of experimental inoculations with
L. monocytogenes, in rabbits, dates back to the first study
describing this pathogen in 1926 [73]. In the following
decades, before L. monocytogenes was recognized as a
major foodborne pathogen, numerous animal experi-
ments were performed in a large variety of species
including mice, rats, rabbits, guinea pigs, dogs, cats, pigs,
ruminants and non-human primates [23]. Because patho-
genesis and in prticular infection routes were essentially
unknown, studies often compared a large number of
exposure routes (e.g., oral, gastric, intraveneous, intraper-
itoneal, intracerebral, subcutaneous, submucosal, con-
junctival, vaginal and nasal), and different studies
occasionally reported seemingly contradictory results
[23,112,113]. Notably, it is extremely difficult to experi-
mentally produce listeriosis in non-pregnant animals that
resembles naturally occurring disease proves extremely
difficult [23]. Encephalitis or meningoencephalitis are
extremely difficult to evoke unless bacteria are instilled
directly in the cerebrum, partially because animals tend
to die before meningitis can develop [23]. Intravenous,
intraperitoneal and intracerebral routes of exposure reli-
ably lead to disease in non-pregnant animals, but their
relevance for naturally occurring disease appears ques-
tionable [23]. Respiratory routes of infection using
aerosolized inoculum are generally efficient means of
inoculating non-pregnant mice, guinea pigs, hamsters,
rabbits, piglets and non-human primates, and in many
experiments animals succumbed to septicemia [23,75,
114,115]. In experimental infections, non-human pri-
mates developed pyrexia but recovered from aerosol
exposure and gross septicemic lesions were absent upon
post-mortem examination of sacrificed animals, even
though some animals mounted a humoral immune
response after inoculation and bacteria could be isolated
from the blood of some animals post inoculation
[23,115]. Except for chinchillas and certain strains of
mice, oral exposure, even at high dose, rarely leads to dis-
ease in non-pregnant animals, with the exception of very
young animals [23]. However, successful oral inoculation
after starvation has occasionally been reported [116].
Remarkably but consistent with observations from natu-
rally infected animals, in some instances bacteria can be
isolated from experimentally inoculated animals in the
absence of clinical symptoms or pathological lesions,
albeit bacterial concentrations are likely low since cul-
tures had to be kept at refrigerated temperatures for sev-
eral weeks to culture L. monocytogenes from the animal
tissues, thereby hampering the growth of background
microflora and allowing the psychotropic bacteria to
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inoculation produces conjunctivitis and other eye infec-
tions in non-pregnant animals of various species includ-
ing rabbits, guinea pigs and non-human primates, and
exposed animals occasionally develop septicemia, menin-
gitis or meningoencephalitis [23,118-120]. Non-human
primates mostly develop mild and transient ocular symp-
toms while guinea pigs and rabbits develop severe symp-
toms and occasionally succumb to systemic infection
[120]. Irrespective of exposure route or animal species,
inoculation of non-pregnant animals often leads to gen-
eralized septicemia, even in ruminants, and sustained
septicemia occasionally - though not reproducibly -
results in meningitis or meningoencephalitis [23,113].
Importantly, the clinical manifestation of experimental
infection appears highly dose-dependent; high inoculation
doses tend to lead to peracute death without visible invol-
vement of the central nervous system [23,113,115]. Focal
necrosis of the liver with infiltration of mononuclear cells
is a typical histopathological finding in septicemic animals,
sometimes also affecting the spleen, lungs, and other
organs such as the tonsils, intestinal tract or adrenal
glands [23,113,121]. In general, susceptibility to infection
differs with L. monocytogenes strain, inoculation dose, age
group - with suckling mice particularly susceptible to
infection-, animal species and also immune status
[23,75,115,122]. For example, it was found that injecting
mice with Bacillus Calmette-Guérin (BCG, a vaccine
against tuberculosis) prior to L. monocytogenes challenge
increases resistance to listeriosis, while experimentally
induced stress reduces resistance, at least in hamsters, gui-
nea pigs and possibly in lemmings [75,123]. Guinea pigs,
hamsters, dogs, cats and pigs overall appear considerably
more resistant to infection than rabbits and mice; in gui-
nea pigs focal necrotic lesions appear atypical in that they
are often limited to the myocardium [23,115,123].
5.2 Experimental infections in pregnant animals
Pregnancy-associated listeriosis has been studied in rumi-
nants and several monogastric species using a variety of
exposure routes [23]. Regardless of placentation type,
gestational stage and exposure route, experimental inocu-
lation of pregnant animals often results in abortion
[23,122,124]. Oral inoculation efficiently produces abor-
tion, as demonstrated for example in pregnant rabbits and
goats [23]. Perinatal infection through vaginal contamina-
tion was also shown to be possible, but rarely occurs even
under experimental conditions [23,113]. In guinea pigs
and rabbits abortion following conjunctival challenge has
also been reported [23,122,124].
Clinical manifestations clearly differ by gestational stage
at the time of inoculation and infectious dose [122,124].
Placentitis, endometritis and focal necrosis are common
findings in aborted animals, and live borne animals often
succumb to septicemia or meningoencephalitis, depending
on the length of the time interval between birth and the
onset of disease symptoms [23,122]. Placentitis and the
resulting nutritional limitations for the fetus seem to play
a major role in the development of abortion. In the pla-
centas of experimentally infected rats necrotic lesions are
predominantly focused in the junctional zone of the pla-
cental disc, but often extend to the labyrinth and metrial
glands, and maternal sinuses are infiltrated with mono-
cytes and polymorphic cells [23,125]. Importantly, crossing
of L. monocytogenes through the placental barrier in the
absence of placental lesions has also been described
[23,126].
6. Mouse models of non-pregnancy-associated
listeriosis
Since the identification of L. monocytogenes as a major
human food-borne pathogen in the early 1980s, consider-
able attention has been devoted to oral or intragastric
routes of exposure. Infection through the oral route is
thought to be the most relevant for humans but poses
considerable practical challenges. For a long time, mice
and to a lesser extent rats were the most popular species
used to establish oral models of listeriosis, predominantly
evaluating septicemic death [11,27,127,128]. The devel-
opment of invasive disease in these animals is dose-
dependent, but in adult animals relatively high doses are
often required to invoke disease and death [11,127,128].
Despite these limitations, murine and rat models
have proved instrumental in elucidating key aspects of
L. monocytogenes infection and immunity, and for
instance have allowed establishment of a correlation
between reduced gastric acid levels and increased sus-
ceptibility to infection, which had been suggested
through epidemiological studies in humans [128-130].
Due to the difficulty of reproducibly invoking and moni-
toring disease in mice after experimental inoculation,
death was often chosen as the study endpoint and the
dose at which 50% of inoculated mice died (i.e., median
lethal dose, or LD50)w a sc o m m o n l yu s e dt oc o m p a r e
results across studies. Other study outcomes such as bac-
terial concentrations in different organs or ratios of dif-
ferent L. monocytogenes strains used in the inoculum
cocktail (i.e., competitive indexing), which represent
commonly chosen study outcomes in most other animal
species, have occasionally been used in mouse studies of
listeriosis. As reported above, neurological symptoms
have proven particularly difficult to evoke experimentally.
However, repeated oral challenge of mice with sublethal
doses (i.e., 5 × 10
9 cfu) has been shown to lead to the
establishment of CNS symptoms, at least in some of the
animals [131]. Notably, repeated dosing over a longer
time period (i.e., 10 vs. 7 consecutive days) appears to
result in a somewhat higher prevalence of CNS
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result in the development of clinical CNS symptoms,
emphasizing the potentially paramount importance of
multiple dosing [131].
6.1. Susceptibility differences among mouse strains
The susceptibility of mice to L. monocytogenes infection is
affected by the physiological state of the animal and differs
considerably among mouse strains [132-140]. LD50 values
for different mouse strains and exposure routes often dif-
fer by several orders of magnitude (Table 1), even though
differences in experimental design (e.g., inoculums size,
preparation and quantification of inoculum, animal sex
and age group, number of days of follow-up after inocula-
tion, L. monocytogenes strain used for inoculation, use of
bicarbonate treatment, starvation or immune suppression
prior to inoculation, method of LD50 calculation, etc.)
complicate comparison across studies. Mice of strains A/J
or BALB/c, for example, are considerably more susceptible
to intragastric as well as intraveneous and intraperitoneal
infection than mice of strain C57BL/6, with reported intra-
gastric LD50 values equaling 10
6 and 10
8 cfu for mice of
strains A/J and C57BL/6, respectively [137,138,141].
The physiological or immunological determinants of
these susceptibility differences have so far only been par-
tially elucidated. After bicarbonate treatment, mice of
strains BALB/c and C57BL/6 developed more marked gas-
tric and intestinal lesions in response to oral inoculation
with 10
9 cfu L. monocytogenes than mice of strains ICR,
C3H and FVB, potentially indicating mouse strain-specific
differences during the intestinal phase of infection [162].
Certain mouse strains probably also differ in the ability to
control infection in the liver since differences in the size
and frequency of hepatic lesions between mice of suscepti-
b l es t r a i nB A L B / ca n dr e s i s t a n ts t r a i nC 5 7 B L / 1 0h a v e
been described [163].
Susceptibility differences are at least partially genetically
determined: mice of strain C57BL/6 and related sublines
NZB and SJL appear considerably more resistant to intra-
venous inoculation than mice of strains A/J, BALB/c or
CBA, and LD50 values equaling 9 × 10
5 and 4 - 8 × 10
3,
respectively, have been reported [138]. Back-crossed
(C57BL/6 × BALB/c) mice, on the contrary, showed inter-
mediate susceptibility with LD50 values in the range of
3.4 × 10
4 cfu [138]. Notably, the degree of susceptibility to
infection also varies among individual back-crossed ani-
mals, possibly indicating that susceptibility differences are
controlled by multiple genetic loci [138,164]. Many labora-
tory mice strains are intentionally bred for their distinctive
immunological characteristics, and these immunological
differences probably represent one of the key determinants
of susceptibility differences to L. monocytogenes infection.
Susceptibility of the A/J strain and certain other strains
such as DBA/2, for instance, appears to be linked to allelic
variation in the Hc locus, which controls complement C5
levels in the mouse [133,164,165]. Yet, other L. monocyto-
genes susceptible mouse strains such as BALB/c are C5-
sufficient, strongly suggesting the presence of additional
susceptibility determinants [133].
Differential cytokine expression during infection likely
contributes to susceptibility differences among inbred
mice strains. After intravenous inoculation with 6 × 10
3
cfu of L. monocytogens, interleukin transcription levels, in
particular IL-12 and IL-15, were higher in dendritic cells
from spleens of C57BL/6 mice than in dendritic cells from
spleens of BALB/c mice [166]. Mice of strain C57BL/6
also expressed higher INF-g and GM-CSF levels in the
spleen shortly after infection than mice of strain A/J, even
though levels in the liver appeared similar [167]. Differ-
ences in susceptibility between C57BL/6 substrains
C57BL/6 J and C57BL/6By after intravenous L. monocyto-
genes inoculation have been linked to differential Ifnb1
expression, with increased IFNb levels increasing suscept-
ibility to infection, thus emphasizing the potentially impor-
tant role of cytokine expression in strain susceptibility
[132].
Sex may directly impact susceptibility of adult mice to
L. monocytogenes infection, potentially due to differences
in IL-10 expression, even though contradictory results
have been reported [168]. Pasche et al., for instance,
showed that, based on survival time differences after chal-
lenge, female mice of strains BALB/c, C57BL/6, C3H/HeN
and CBA/J were significantly more susceptible to intrave-
nous inoculation than concurrently inoculated male mice
of the same strains, with associated p-values ranging from
0.002 to 0.05 for the different strains [168]. Mainou-
Folwer, on the contrary, did not detect significant differ-
ences in LD50 values between male and female mice of
BALB/c or C57BL/6 strains after intraveneous inoculation
[139], and Cheers and McKenzie did not detect marked
differences in survival between male and female mice of
various strains including BALB/c, CBA and C57BL/6
[138].
Age significantly impacts susceptibility to infection. For
instance, LD50 values for specific pathogen free (SPF)
sucking mice of strain ddY after intragastric inoculation
have been shown to be approximately 10
5 cfu lower than
those for 5 week old SPF animals of the same strain
[127]. Pine et al. demonstrated approximately 10 fold dif-
ferences in susceptibility of 21 compared to 33 day old
female mice of strain NCR after intragastric L. monocyto-
genes inoculation, regardless of the L. monocytogenes
strain used [17]. Backcrossed (A/Tru × C57BL/6) mice 1,
8 and 24 months of age exhibited LD50 values of 1.6 ×
10
4, 4.0 × 10
6 and 1.6 × 10
5 cfu, respectively, when inocu-
lated intravenously with L. monocytogenes strain EGD,
even though age differences were not observed when
mice were inoculated with low bacterial doses [144].
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Page 9 of 27Table 1 Susceptibility of some mouse strains used as models of non-pregnancy-associated L. monocytogenes infection,
measured as median lethal dose (LD50)
mouse strain LD50 range (in CFU) reported in the literature Recognized mouse
phenotype
oral/intragastric intravenous intraperitonial
LD50 (strain) Reference LD50 (strain) Reference LD50 (strain) Reference
A/J 10
6 (a) [137] 10
3 (b, d) [138,141] <1 0
7 -1 0
11 (b, d,e, i) [142,143] susceptible
A/Tru × C57Bl/6
7 10
4 (b) [144] -
A/Tru × C57Bl/6
4 10
6 (b) [144] -
A/Tru × C57Bl/6
8 10
5 (b) [144] -
A/WySn 10
4 (d) [138] -
BALB/c 10
3 (b, d) [138,145] 10
5 (i) [147] susceptible
10
4 (c) [146]
10
5 (f, i) [139]
B10.A 10
5 (b,d) [138,141] resistant
B10.D2/Sn 10
5 (b, d) [138,141] resistant
CBA 10
3 (d) [138] susceptible
C3HeB/FeJ 10
4 (i) [148] susceptible
C57BL/6 10
3 (b) [145] 10
3 (b) [145] resistant
10
8 (a) [137] 10
5 (b) [149]
>1 0
10 (b) [149] 10
6 (d, f, i) [138,139]
C57BL/6 × BALB/c 10
3 (b) [42] intermediate
10
4 (d) [138]
C57BL/6 × DBA/2 N 10
4 (b) [150] 10
7 -1 0
9 (b, e, i) [143] intermediate
C57BL/10Sn 10
5 (b) [141] resistant
DBA/2 J 10
3 (b) [141] susceptible
ddY
3 10
4 (g) [127] -
ddY
4 >10
9 (g) [127] -
ICR 10
5 (d) [151] 10
4 -1 0
7 (a,d,e,i) [152] intermediate
10
4 - >10
8 (b,d,i) [19,153]
10
5 - >10
9 (a,d,e,i) [154]
Inbred white
(Washington State
University)
10
5 -1 0
7 (c) [155] -
NCR
1 10
1 -1 0
5 (d, e, i) [17] 10
1 -1 0
5 (d, e) [17] -
NCR 10
3 -1 0
6 (d, e,i) [17] 10
2 -1 0
6 (d, e,i) [17] -
NMRI
5 10
4 (f) [156,157] 10
4 -1 0
12 [158] -
10
4 -1 0
12 (f,g,h,i) [158] (f,g,h,i)
Swiss 10
5 (b) [159] -
Swiss-Webster 10
1 -1 0
5 (i) [115] -
10
5 -1 0
7 (c) [155]
Swiss white 10
7 (a,d,e) [18] -
Porton >10
10 (b,d,e,i) [160] -
129 Sv × C57BL/6 10
4 (b) [161] intermediate
iFABP-hEcad
2 ~10
10 (b) [149] transgenic
E16PmEcad
6 n/a transgenic
Animals represent non-pregnant adults unless stated otherwise.
1body weights ranging from 10 - 20 grams;
2(C57BL/6 J × SJL/J) background;
3suckling mice;
4adult mice;
5derived from swiss-type mouse;
6only competitive
indexing experiments performed;
7juvenile mice;
8geriatric mice
L. monocytogenes strains:
(a) L.monocytogenes Scott A (serotype 4b); (b) L.monocytogenes EGD (serotype 1/2a); (c) L. monocytogenes 10403S (serotype 1/2a); (d) human clinical isolate; (e)
food isolate; (f) L. monocytogenes 4b isolate; (g) L. monocytogenes 1b isolate; (h) L. monocytogenes 3a isolate; (i) other or not specified L. monocytogenes isolate.
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determinants therefore impact susceptibility of mice to
L. monocytogenes infection, and may complicate compari-
sons across studies.
6.2. Pathogenicity differences among L. monocytogenes
strains
Regardless of the mouse strain or the host’s physiologi-
cal status, susceptibility of mice to intragastric as well as
other routes of inoculation clearly depends on the
L. monocytogenes strain used for inoculation (Table 1).
For example, when mice of the BALB/c strain were
inoculated through the intragastric route with 2 × 10
9
cfu of different L. monocytogenes strains, bacterial loads
in internal organs clearly differed among L. monocyto-
genes strains [169].
L. monocytogenes strains are known to differ in their
pathogenicity for humans, and the molecular determinants
of these pathogenicity differences are beginning to be elu-
cidated [55]. Notably, while a large fraction of strains iso-
lated from food sources contain a premature stop codon
in the inlA gene that attenuates their virulence, such atte-
nuated strains are rarely isolated from human cases, and
outbreak strains generally express full-length InlA [55].
Similar to these pathogenicity differences among humans,
mice appear to be more susceptible to infection with
human outbreak strains than with isolates from food
sources. For example, systemic infection was significantly
(p < 0.01) more likely in mice of strain A/J inoculated with
10
6 CFU of epidemic L. monocytogenes strains from
human outbreaks than in mice inoculated with similar
amounts of L. monocytogenes strains from environmental
or food sources [136]. Similarly, after challenging adult
mice of the NCR strain with different L. monocytogenes
isolates from clinical and food source, LD50 values ranged
from 10
3 to 10
5 cfu [17]. In outbred mice of the ICR
strain, intragastric inoculation with 10
6 cfu of L. monocyto-
genes Scott A, a serotype 4b strain, led to pathologically
more severe lesions than inoculation with equal amounts
of L. monocytogenes s t r a i nE G D ,as e r o t y p e1 / 2 as t r a i n ,
again reflecting pathogenicity trends among humans [170].
Surprisingly, pretreating mice with sodium bicarbonate to
neutralize the stomach pH appeared to have a consider-
ably more pronounced effect on infections with strain
EGD than on infections with the Scott A strain [170].
Similarly pronounced differences among L. monocytogenes
subtypes have been observed in pregnant gnotobiotic
BALB/c mice after oral challenge, with a serotype 3 strain
apparently unable to colonize the murine gut and invade
the host [154]. Back-crossed (C57BL/6 × DBA/2) mice,
inoculated intragastrically with 2 × 10
9 cfu of hemolytic or
non-hemolytic L. monocytogenes strains showed consider-
ably different bacterial loads in mesenteric lymph nodes,
spleen and liver, again emphasizing the similarities in
L. monocytogenes strain specific pathogenicity between
mice and humans [171]. Properties of the inoculum strain,
in addition to immunological and physiological properties
of the host, therefore seem to significantly impact the out-
come of experimental L. monocytogenes inoculations in
mice, and L. monocytogenes strain specific pathogenicity
differences in mice may at least partially reflect pathogeni-
city differences in humans.
7. Species-specific interactions between
internalines and host cells
Discovery of the InlA and InlB dependent mechanisms by
which L. monocytogenes is thought to transgress the
intestinal and placental barriers has resulted in a critical
re-evaluation of mice and other traditional small animal
models of listeriosis [24]. L. monocytogenes invasion pro-
teins InlA and InlB are members of the internalin family,
proteins with leucine-rich repeats (LRRs) [172]. Experi-
mental inoculations in a variety of animal species, in pri-
mary cell lines, organ explants and immortalized cell
lines using L. monocytogenes wild type, inlA, inlB and
inlA/inlB deletion mutations and an inlA expressing
L. innocua mutant have provided compelling evidence
for the roles of these bacterial proteins in mediating
internalization of L. monocytogenes into nonphagocytic
cells [24]. The N-terminal regions of InlA and InlB con-
tain signaling peptides and LRRs [172]. The C-terminal
region of InlA contains a conserved LPXTG motif that
confers covalent binding to peptidoglycans on the bacter-
ial cell surface, while InlB contains a G-W motif, result-
ing in non-covalent binding to lipoteichoic acids in the
bacterial cell wall [172,173]. Notably, due to the non-
covalent nature of the binding InlB can be liberated from
the bacterial cell wall, a process that is thought to play
intricate roles during infection [174].
The importance of InlA for L. monocytogenes entry into
non-phagocytic cells was demonstrated in 1991 when
L. monocytogenes InlA was shown to confer L. innocua the
ability to enter human Caco-2 cells (origin: human epithe-
lial colorectal adenocarnicoma) and this finding has since
been repeatedly confirmed [172,175,176]. Analogously,
InlB has been shown to be required for L. monocytogenes
internalization into various cell types such as immortalized
Vero (origin: African green monkey kidney), HeLA (origin:
human cervical adenocarcinoma), and CHO (origin:
Chinese hamster ovary) cells [173,177]. An in vivo role of
InlA and/or InlB, which are both encoded by the inlAB
operon, for L. monocytogenes infection was suggested by
Gaillard et al. in 1996, using a L. monocytogenes EGDΔ
inlA/inlB deletion mutant [36]. After oral or intravenous
challenge of SPF female Swiss mice with 10
9 or 10
5 cfu of
the L. monocytogenes EGDΔ inlA/inlB deletion mutant,
Gaillard et al. detected bacterial concentrations in the liver
that were considerably lower than after challenge with
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challenge equaled 5 × 10
6 and 3.5 × 10
7 for EGD wt and
EGDΔ inlA/inlB, respectively [36]. Gaillard et al. also
showed a reduced ability of L. monocytogenes EGDΔ inlA/
inlB to invade TIB-73 cells, an immortalized hepatocyte
line derived from BALB/c mice [36].
7.1 Interactions between E-cadherin and InlA
E-cadherin (Ecad, Ca
2+ dependent selective hemophilic
adhesion molecule) is a transmembrane adhesion protein
that mediates cell-cell junctions on epithelial cells and
plays essential roles during embryonic development
[172,174]. Ecad is expressed on most epithelial cells, but
seems to be frequently replaced by P-cadherin on tumor
cells, which may caution against the use of certain
tumor-derived cell lines for the study of E-cadherin
expression [178]. Ecad expression on polarized epithelial
cells is typically located in adherence junctions and on
the basolateral surface [172]. E-cadherin was identified as
InlA receptor in 1996, again using human Caco-2 cells
[179]. LCAM, a chicken ortholog of human Ecad, which
shares approximately 65% sequence homology with Ecad
[180], has been shown to promote InlA dependent entry
into transfected immortalized fibroblast cell lines S180
(origin: Swiss mouse sarcoma) and L2071 (origin: C3H/
An mouse connective tissue), providing convincing evi-
dence that Ecad is sufficient to promote L. monocytogenes
entry into these nonphagocytic cells [177,179]. The
mechanism of InlA-mediated entry has since been eluci-
dated: interactions between InlA and Ecad, located in
lipid rafts, trigger intricate intracellular cascades that lead
to actin rearrangement and ultimately result in caveolin-
dependent endocytosis [11,172,174,181,182].
Murine Ecad (mEcad) has been cloned and studied
extensively, primarily due to the crucial role of this mole-
cule in cell sorting and cell-cell recognition during embry-
ogenesis [180,183]. mEcad and human E-cadherin (hEcad)
share approximately 85% sequence identity [180]. Surpris-
ingly, however, L. innocua expressing InlA appeared
unable to enter murine NMe cells (derived from NMuMG
cells, an immortalized line of mouse mammary epithelial
cells [180,184]), even though these cells have been shown
to express high mEcad levels [180]. Similarly, transfection
of various immortalized cell lines with mEcad (a cDNA
construct originally derived from murine F9 embryonal
carcinoma cells (i.e., an immortal cell line derived from
129/Sv inbred mice) for structure/function studies
[180,185-187]) failed to promote entry of the L. innocua
mutant expressing InlA, even though this L. innocua
mutant readily entered the same cell lines transfected with
human Ecad or chicken LCAM [180]. The inability of
mEcad to promote InlA-dependent entry has been linked
to a P16E mutation in the first extracellular domain of
mEcad [180]. The sequence of rat Ecad at position 16 of
this domain, also a glutamic acid, was determined using
immortalized NBT2 (origin: rat bladder carcinoma) cells
[180]. Guinea pigs, rabbits and gerbils, on the contrary,
harbor a proline at position 16 [12,180,188]. This informa-
tion was determined using GPC16 cells (origin: guinea pig
colorectal adenocarcinoma), rabbit corneal epithelial cell
cultures, and gerbil primary intestinal epithelial cell cul-
tures [12,180,188].
The inlA gene of L. monocytogenes strain EGD has been
successfully “murinized”, leading to considerably increased
susceptibility of wild type mice to infection with the muri-
nized L. monocytogenes strains [189,190]. Two point muta-
tions (i.e., S192N and Y369S) located in the inlA gene of
murinized L.monocytogenes strain EGD-InlA
m, have been
shown to lead to increased susceptibility of C57BL/6 and
BALB/c mice to oral infection, resulting in an LD50 of
approximately 5 × 10
7 CFU in C57BL/6 mice, while only
approximately 20% of C57BL/6 mice challenged with 5 ×
10
10 cfu of wild type EGD died [189,190]. An N259Y
mutation in L. monocytogenes EGD inlA has also been
shown to promote efficient infection of BALB/c mice after
intra-gastric inoculation [190].
iFABP-hEcad transgenic mice, generated in a (C57BL/6 J
× SJL/J) background, express hEcad under control of the
iFABO promoter [149]. In these mice, hEcad expression is
limited to the intestine while mEcad is expressed on all
epithelial cells that express mEcad in wild-type mice.
iFABP-hEcad mice showed 85% mortality after oral chal-
lenge with 5 × 10
10 CFU of L. monocytogenes strain EGD
while 100% of wild-type mice of the same murine strain
and challenged under identical conditions survived [149].
This translates into LD50 values of > 10
10 and approx.
10
10 for wild type and iFABP-hEcad mice, respectively
(Table 1). Notably, 100% of wild type and transgenic mice
challenged with the same dose of EGDΔinlA,a ninlA
knock-out strain of L. monocytogenes EGD, survived [149].
These results are comparable to those obtained for guinea
pigs challenged with 5 × 10
11 CFU of EGD or EGDΔinlA,
respectively, with the LD50 for wt EGD in guinea pigs
equaling approx. 10
11 cfu [149]. Like (starved) wild type
mice, (starved) gnotobiotic Fabpi-hEcad mice, generated
by back-crossing iFABP-hEcad transgenic mice to mice of
strain C57BL/6 J and reared under gnotobiotic conditions,
did not exhibit mortality after oral inoculation with 10
9
cfu of EGD or EGDΔinlA, even though some clinical
symptoms were reported [191]. Notably, in gnotobiotic
Fabpi-hEcad mice, EGD was detected in villus enterocytes
and the underlying lamina propria while such observations
were not made in wild type mice [191]. However, L. mono-
cytogenes EGDΔinlA strains were able to infect the spleen
of gnotobiotic Fabpi-hEcad mice, albeit at levels below
those observed in Fabpi-hEcad mice infected with EGD,
strongly indicating the presence of alternate infection
pathways in these mice [191].
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a carry a point mutation at
position 16 of the first extracellular domain of murine
E-cadherin that changes the glutamic acid at this posi-
tion to a proline (i.e., E16P mutation) [12]. E16PmEcad
mice are homozygous and therefore exclusively express
“humanized” E-cadherin on all tissues where murine E-
cadherin is expressed in wild-type mice [12]. In (starved)
E16PmEcad mice experimental inoculation with 10
9 cfu
EGD, InlA-dependent crossing of the intestinal barrier
has been observed [12]. Unfortunately, information as to
whether deaths were observed with this challenge dose
was not provided and the available data do not permit
calculation of LD50 values [12].
7.2 InlB and its three receptors
The hepatocyte growth factor receptor (HGFR or MET),
complement component 1 Q subcomponent-binding pro-
tein (gC1qR) and glycosaminoglycans are known receptors
for InlB and have been shown to mediate L. monocytogenes
entry into a broad variety of host cells [192-194]. gC1pR is
a ubiquitous, multiligand binding glycoprotein and acts as
receptor for complement C1 [172]. Specific interactions
between gC1pR and InlB have been documented and
gC1pR and MET appear to act synergistically [173]. MET,
a receptor tyrosine kinase, is expressed on a wide variety
of epithelial and endothelial cells and binds hepatocyte
growth factor (HGF) with high affinity [192-194]. MET is
important for normal embryonic development, but also
appears to play a key role in oncogenesis [173]. InlB bind-
ing leads to MET activation through transient phosphory-
lation of its multiple docking sites [173]. A complex
intracellular cascade (see for instance [173,174] for a
review) subsequently leads to actin reorganization, mani-
fested as “membrane roughing”, and culminates in cla-
thrin-mediated endocytosis [173,174]. MET activation
through HGF binding is considerably enhanced by the
presence of glucosaminoglycanes (GAG) on the cell sur-
face [173]. Notably, the C-terminus of InlB has also been
shown to bind GAGs on the host cell surface, and InlB-
dependent invasion is impeded in the absence of GAG
[173,194].
The importance of InlB for L. monocytogenes infection
has been demonstrated in-vivo and in-vitro. Bacterial
counts in the liver and spleen of BALB/c mice, intrave-
nously inoculated with 3 × 10
3 cfu of EGDΔinlB, were sig-
nificantly (p < 0.02) lower 72 h after inoculation than in
mice inoculated with the same dose of EGD wt, strongly
suggesting a role of InlB-dependent colonization of these
organs during L. monocytogenes infection in mice [45].
Surprisingly, however, such InlB dependence was neither
observed in (starved) guinea pigs inoculated intragastri-
cally with 10
10 cfu (plus calcium carbonate) or intrave-
nously with 10
6 cfu of the same L. monocytogenes strains,
nor in rabbits inoculated intravenously with 10
6-10
7 cfu of
the same strains [45]. Species-specific differences in inter-
nalization efficacy were confirmed in-vitro using immorta-
lized cell lines of human, mouse, rabbit, and guinea pig
origin
b [45]. Nearly all tested cell lines from guinea pigs
and rabbits expressed both MET and gC1qR [45]. How-
ever, in guinea pig derived cell lines neither InlB nor
human HGF induced membrane ruffling, a prerequisite
for InlB dependent internalization [45]. In rabbit-derived
cells, the presence of human HGF, but not InlB, induced
such membrane ruffling [45]. Surprisingly, transfection of
human MET conferred permissiveness in guinea pig and
rabbit cell lines, indicating likely species-specific receptor
differences [45]. In gerbils, both InlA and InlB mediated
entry pathways appear to be functional as determined
using primary intestinal cell cultures and confirmed in
vivo using pregnant gerbils, but calculation of LD50 values
has so far unfortunately not been possible [12]. Gerbils
may conceivably represent an attractive rodent model of
L. monocytogenes infection [12]. As perhaps expected for a
rodent species, gerbils appear to cluster with mice and rats
in dendograms based on either the Ecad or the MET
sequence, but may form a separate phylogenetic clade in
the Ecad phylogeny [12].
Other, currently unknown species-specific differences
may exert so far unrecognized impacts on L. monocyto-
genes infections. Various L. monocytogenes virulence pro-
teins such as listeriolysin O or ActA have been shown to
play crucial roles in the L. monocytogenes infection path-
way, while the role of other proteins is just beginning to
be recognized [24]. Vip, for instance, encodes another
L. monocytogenes LPXTG surface protein, which interacts
with endoplasmatic reticulum resident chaperon Gp96
[195]. Guinea pigs as well as iFABP-hEcad transgenic mice
have been shown to harbor lower bacterial loads in the
liver, intestine, lymph nodes and spleen when orally inocu-
lated with 10
10 cfu or 5 × 10
9 cfu, respectively, of L. mono-
cytogenes EGDΔvip than when inoculated with the same
doses of wt EGD, and similar observations have been
made in BALB/c mice after intravenous inoculation [195].
Potential differences in vip-Gp96 interactions in other ani-
mal species, however, remain yet-to-be determined. As the
interactions between L. monocytogenes and its host are
increasingly being understood, new criteria for the ade-
quacy of animal models of human listeriosis will likely
continue to emerge.
8. Other animal models of non-pregnancy-
associated listeriosis
The mouse model has been the most commonly used
animal model of L. monocytogenes infection due to its
size, ease of handling, and relatively low economic cost
[11,23]. Moreover, the commercial availability of many
reagents for immunological studies, the extensive avail-
able data on mouse physiology, anatomy, embryogenesis
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ized inbred mouse strains with known physiological and
immunological characteristics have contributed to the
immense popularity of the non-pregnant mouse model
of listeriosis. However, as discussed below, other small
animal species have also occasionally been used to study
certain aspects of L. monocytogenes infection and immu-
nity in non-pregnant animals (Table 2). Since the spe-
cies-specific differences in InlA-Ecad and InlB-MET
interactions have been discovered, the value of mice, as
well as rats, guinea pigs and rabbits as models for lister-
iosis in humans has been questioned [11]. Non-human
primates or unconventional small-animal models, such
as gerbils, may ultimately prove to be superior models
of listeriosis, but only limited data on L. monocytogenes
infections and immune responses in these animal spe-
cies are so far available and ethical, economic and prac-
tical considerations, especially for non-human primates,
will necessarily limit the number and size of studies that
can be performed in these animal species.
8.1. Non-pregnant rat models
Non-pregnant rats have been used repeatedly as models of
L. monocytogenes infection, and rat antibodies have been
used in mice to study the immunology of listeriosis
[25,33,196-203]. Formal LD50 values after oral inoculation
of adult rats are not available in the literature, but rats
appear to be relatively resistant to infection. For example,
juvenile rats orally inoculated with 10
2-10
9 cfu of a
L. monocytogenes 4b strain developed dose-dependent
invasive infection as measured by the presence of cultur-
able bacteria in internal organs, but did not exhibit clear
clinical symptoms or death [128,197]. Notably, treatment
with cimetidine, a histamine receptor agonist that inhibits
acid production in the stomach, significantly (p <0 . 0 5 )
increased the probability of invasive infection in rats
inoculated with less than 10
9 cfu, but did not significantly
(p > 0.05) affect bacterial counts in the liver or spleen of
infected animals, and bacterial counts in the organs did
n o ta p p e a rt ob ed o s ed e p e n d e n t( p > 0.05) [197]. LD50
values for infant rats inoculated 3 days post-partum and
juvenile rats, inoculated 13 days post-partum, determined
after subcutaneous injection of an L. monocytogenes sero-
type 4b strain, equaled 6 × 10
5 and 2.5 × 10
7, confirming
the relatively high infectious dose for rats [204]. Rats have
also for instance been used to study the impact of the gut
microflora on susceptibility to infection [202]. In these
experiments the presence of a normal gut microflora
appeared to be somewhat protective of L. monocytogenes
infection [202]. Gnotobiotic rats orally inoculated with 2 ×
10
9 cfu of a L. monocytogenes serotype 1 strain exhibited
weight loss, splenomegaly and histopathological lesions,
and bacteria were readily recovered from the spleen and
liver, even though rats appeared clinically healthy [202]. In
conventionally reared rats or gnotobiotic rats switched to
conventional feed during the experiment, however,
L. monocytogenes appeared to be efficiently cleared from
internal organs [202]. Rat ligated intestinal loop systems
have been used to study early intestinal steps of L. monocy-
togenes infection - even though the Ecad receptor differ-
ences discussed above have since raised concern about the
relevance of this system for modeling human infection
[11,25,33]. Analogous to mice, rat models of L. monocyto-
genes infection have been used to study immune responses
to infection [201]. Young rats have also been used to
establish rat models of meningitis, and to evaluate the
impact of different therapeutic regimens in these models
[200]. For instance, in one of these experiments, rats were
inoculated by intracisternal injection of 5 × 10
4 -1×1 0
5
cfu of an L. monocytogenes 4b strain and developed
depression, weight loss and meningitis within one day of
inoculation [200].
8.2 Non-pregnant guinea pig models
Non-pregnant guinea pigs have been used as models for
listeriosis, even though inoculations have also often been
performed in pregnant guinea pigs [16,53,205-208].
Guinea pigs appear to be somewhat more resistant to
infection than most strains of mice, irrespective of the
inoculation route [23]. High numbers of bacteria appear to
be required to install infection in non-pregnant guinea
pigs. LD50 values of about 10
11 cfu and greater than 10
8
cfu have been reported for oral and intraperitoneal inocu-
lation, respectively [149,205], and for this reason, a stan-
dard dose of 10
10 cfu of L. monocytogenes EGD has been
suggested for oral inoculation of guinea pigs, compared to
doses of 10
8 -5×1 0
9 cfu for mice [209]. Guinea pigs
appear most susceptible to inoculation through the intra-
cardial route, with an LD50 value of 1.2 × 10
5 cfu, while
intravenous and intraperitoneal LD50 values appear to be
high, in the range of 10
7 -1 0
8 cfu and > 2.5 × 10
8, respec-
tively [205].
Other infection endpoints than death have occasion-
ally been used in guinea pig studies and guinea pigs
have for instance been used to identify differences in
infectious doses among L. monocytogenes strains after
oral inoculation [210]. Infectious doses of 10
7-10
8 cfu
after oral inoculation of juvenile male guinea pigs with
an L. monocytogenes strain carrying a point mutation in
inlA, and approximately 1 log lower infectious doses for
inoculations with outbreak strains without the inlA
mutation, have been reported [210]. Other researchers
have also reported the ability to reproduce differences in
L. monocytogenes pathogenicity among strains using
orally infected non-pregnant guinea pigs [211]. However,
infectivity again appeared to be relatively low. Rolgaard
et al., for instance, gave two doses of 2 × 10
10 cfu each
to the animals, one day apart [211]. He noted no deaths
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clinical symptoms such as depression and ruffed coat in
o n l yaf e wo ft h ea n i m a l s ,o nt h ed a yo fe u t h a n a s i a ,
even though bacteria could be harbored from the organs
of most animals [211]. Oral inoculations of (starved)
guinea pigs in the presence of calcium carbonate with
10
10 cfu of different L. monocytogenes strains led to
reduced weight gain but did not cause noticeable clinical
symptoms, perhaps again indicating a comparably low
susceptibility to infection, even though the observation
Table 2 Summary of benefits and limitations of the different animal models (see text for details and references)
Non-pregnant animals Pregnant animals
Species Popularity Benefits Limitations Popularity Benefits Limitations
mouse high moderate/
high
- same as for non-
pregnant animals
- similarities to
human
- placentation well
characterized
- mutation in receptor for InlA
(Ecad)affects crossing of
placental barrier
- small body size
rat moderate - well characterized
- economical
- large sample size
possible
- inbred strains
available
- immune reagents
available
- body size optimal
for certain
manipulations
- proven ability to
model bacterial strain
variability
- mutation in receptor for InlA
(Ecad)affects entry into
enterocytes
- quite resistant to infection
moderate - same as for non-
pregnant animals
- similarities to
human
placentation
- body size optimal
for certain
manipulations
- mutation in receptor for InlA
(Ecad) affects crossing of
placental barrier
- quite resistant to infection
rabbit moderate/
low
- well characterized
- economical
- large sample size
possible
- commonly used to
generate antibodies
- quite susceptible to
infection
- InlB receptor (MET)
polymorphism affects entry into
cells such as hepatocytes
moderate/
low
- same as for non-
pregnant animals
- similarities to
human
placentation
- body size
optimal for certain
manipulations
- mutation in InlB receptor
(MET) affects crossing of
placental barrier
guinea
pig
moderate - well characterized
- economical
- large sample size
possible
- body size optimal
for certain
manipulations
- ability to model
bacterial strain
variability
- InlB receptor (MET)
polymorphism affects entry into
cells such as hepatocytes
- quite resistant to infection
- pathological lesions often
limited to myocardium
high - same as for non-
pregnant animals
- similarities to
human
placentation
- body size optimal
for certain
manipulations
- mutation in InlB receptor
(MET) affects crossing of
placental barrier
- quite resistant to infection
gerbil increasing - quite susceptible to
infection
- functional receptors
for InlA (Ecad) and
InlB (MET)
- not very well characterized
- no immune reagents
- small body size less economical
increasing - same as for non-
pregnant animals
- same as for non-pregnant
animals
chinchilla low - highly susceptible - not well characterized
- inlA &inlB receptor sequences
unknown
- no immune reagents less
- economical
low - same as for non-
pregnant animals
- same as for non-pregnant
animals
hamster low - economical - resistant to infection
- inlA &inlB receptor sequences
unknown small body size
low - same as for non-
pregnant animals
- same as for non-pregnant
animals
primate moderate - close phylogenetic
relationship to
humans
- ethical and economic
considerations
- limited sample size
- no immune reagents
moderate - same as for non-
pregnant animals
- same as for non-pregnant
animals
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up after inoculation [212]. Similar observations were
also made in a study to evaluate the potential impact of
food matrix on infectivity [213]. Pang and Matthews did
not detect any clinical symptoms in starved, orally chal-
lenged guinea pigs, even if infectious doses of 10
8 cfu of
a L. monocytogenes serotype 4b strain were used, and
differences in bacterial loads in internal organs between
food matrices were also not detected [213]. Geriatric
guinea pig models have been used to evaluate the
impact of immune modulation in elderly animals [21].
However, intragastric inoculation with 2.5 × 10
8 cfu of a
L. monocytogenes serotype 4b strain again failed to pro-
duce death in the geriatric guinea pigs, and the presence
of clinical symptoms was not described [21].
8.3 Non-pregnant rabbits as models of listeriosis
Rabbits appear relatively susceptible to infection with
L. monocytogenes, even though LD50 values have not been
formally calculated [23]. Rabbits have typically been used
to generate anti-Listeria monocytogenes antibodies and to
study immune responses to L. monocytogenes infection
[214-216]. However, rabbits have occasionally also been
used to model other aspects of L. monocytogenes infection,
for instance to evaluate therapies for listeric meningitis
[217]. Scheld et al., for example, inoculated animals with
relatively high doses of 10
7 cfu of a L. monocytogenes strain
from a human meningitis case by injection into the cis-
terna, and used changes in bacterial concentrations in the
spinal fluid to evaluate the efficacy of different che-
motherapies [217]. Abscess formation after subcutaneous
inoculation of rabbits has also been reported [23].
8.4 Other non-pregnant rodent models
Nontraditional rodent species such as gerbils, chinchillas
and lemmings, have occasionally been used as models of
L. monocytogenes infection [23]. Chinchillas appear to be
highly susceptible to oral inoculation, but seem to have
been rarely used due to economic and practical considera-
tions [23]. Chinchillas and gerbils have been used success-
fully to model listeric rhombencephalitis in animals with
prolonged otitis media and bacteremia [218]. Gerbils were
inoculated with 10
3 or 10
5 cfu of L. monocytogenes EGD
by percutaneous injection into the superior chamber of
the middle ear bulla [218]. Animals inoculated with high
doses succumbed to disease 4-7 days after inoculation,
while animals inoculated with low doses survived for 6-12
days [218]. Most gerbils exhibited behavioral changes, and
typical neurological symptoms such as circling, ataxia, and
paresia were observed at relatively late stages during infec-
tion [218]. Gerbils have also recently been used to model
oral inoculation, even though only a relatively small num-
ber of animals were used and inoculation of 10
9 cfu of
L. monocytogenes EGD did not appear to cause severe
clinical symptoms in these animals [12]. Hamsters have
rarely been used as models of listeriosis, but have been
reported to be comparably resistant to infection [23].
Voles, on the contrary appear to be fairly susceptible to
intra-peritoneal infection, but have rarely been used due
to practical constraints on availability [23].
8.5 Non-human primates as models of listeriosis
Only a small number of experimental studies in non-
human primates have been reported, primarily in pregnant
animals [13,14]. However, Farber et al. inoculated non-
pregnant cynomolgus monkeys with between 10
5 and 10
9
cfu of L. monocytogenes Scott A or a L. monocytogenes ser-
otype 4b isolate from a food source, suspended in sterile
milk, and only detected mild clinical symptoms such as
fever, irritability, inappetence and in some cases diarrhea,
primarily in animals challenged with high doses [15].
Interestingly, no marked differences between the two
L. monocytogenes strains and no impact of treatment with
antacids were observed [15]. One ape was challenged
twice, approximately 8 weeks apart, with 10
9 cfu of
L. monocytogenes Scott A, and fecal shedding in this ani-
mal after the second inoculation appeared shorter than in
monkeys dosed once, potentially indicating some protec-
tive effect of prior exposure [15]. A small number of other
experimental inoculations of non-human primates have
also been reported, establishing for instance that apes
appear to be relatively resistant to ocular or aerosol inocu-
lation, even though transient ocular symptoms or febrile
infection, respectively, could be invoked in these animals
[23,115].
9. Animal models of pregnancy-associated
listeriosis
Pregnancy significantly increases susceptibility to
L. monocytogenes infection, regardless of the animal spe-
cies or route of inoculation [23]. Similar to observations
in non-pregnant animals, mouse strain specific differ-
ences in susceptibility of pregnant mice to L. monocyto-
genes infection have been reported, especially upon
challenge with high doses [219]. Resistant mice strains
exhibit a decreased risk of fetal resorption, lower mor-
tality, and reduced bacterial loads in the liver and spleen
as compared to susceptible mice strains [219]. The bio-
logical determinants of these differences, however, are
currently still largely unclear.
The immunological, anatomical and physiological
determinants of the increase in L. monocytogenes suscept-
ibility during pregnancy have been subject to intense
study, but have so far still only partially been resolved.
Pregnancy is associated with immunological changes that
result in a shift in the Th1/Th2 cytokine balance to favor
Th-2 mediated, humoral responses [219]. Th-1 mediated
cellular immune responses, primarily mediated through
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(TNFa), are crucial for successful control of infections
with intracellular pathogens such as L. monocytogenes,
but appear significantly down-regulated during preg-
nancy [219]. Mouse models have been used extensively
to study immunological changes during pregnancy,
encompassing both physiological changes needed to pro-
tect the fetus and responses elicited following infection.
As shown in comparative studies of pregnant and non-
pregnant female mice of the BALB/c strain, T-cell
mediated immune responses are significantly impaired
during pregnancy and systemic INFg levels are downre-
gulated while IL-10 levels are upregulated [219]. Follow-
ing L. monocytogenes infection, increased systemic levels
of TNFa and IL-6 were detected in pregnant BALB/c
mice compared to non-pregnant female BALB/c mice,
while IL-8 ortholog Chemokine (C-X-C motif) ligand 1
(CXCL1, previously called KC) appeared downregulated,
indicating a likely role in the diminished ability to control
L. monocytogenes infection [219]. Mouse models have
also been instrumental in elucidating pregnancy-asso-
ciated immunological changes in specific tissues. In the
liver of pregnant mice of the BALB/c strain, for instance,
transcription of TNFa,I N F g and inducible Nitric oxide
synthase (iNOS) is decreased after experimental inocula-
tion with L. monocytogenes as compared to non-pregnant
female mice [219]. The ability of the immune system to
control L. monocytogenes replication in the liver, spleen
and other organs therefore appears to be severely ham-
pered during pregnancy.
The intricate immunological and physical roles played
by the placenta in shielding the fetus from infection are
slowly being revealed [219]. The murine placenta appears
to represent a transient component of the innate immune
system [220]. Comparative studies in knock-out mice
identified a crucial role of colony stimulating factor
1 (CSF-1) in the control of L. monocytogenes infection
[220]. After experimental inoculation with 1 × 10
4 cfu of
L. monocytogenes EGD, CSF-1 induced expression of KC
and macrophage inflammatory protein 2 (MIP-2) in the
trophoblast resulted in recruitment of neutrophils, the
predominant immune cells in the pregnant placenta [220].
Notably, wild type mice were able to control the infection
by day 3 post inoculation, and carried their litters to term,
while all knock-out mice aborted [220]. The placenta likely
also encompasses other components of the innate immune
system. For example, Toll-like receptors (TRLs) 2 and 4,
components of the innate immune system that recognize
the surface protein LPS present on the surface of gram-
positive bacteria, are expressed on human placentas and a
role in host defense against L. monocytogenes during preg-
nancy appears likely [221,222].
The placenta may represent an important L. monocyto-
genes h a r b o r a g es i t ed u r i n gp r e g n a n c y ,a n dm a yp l a ya
direct role in mediating increased susceptibility to infec-
tion. For example, inoculation of female non-pregnant and
pregnant mice of strain CD1 through the intragastric
route with 3 × 10
7 cfu L. monocytogenes 10403S (serotype
1/2a) or a serotype 4 non b strain resulted in (extrapo-
lated) LD50 values of approx. 1.5 × 10
8 cfu in pregnant ani-
mals [223]. None of the non-pregnant animals inoculated
with 10
8 cfu died [223]. Surprisingly, bacterial loads in the
colon, spleen and liver after oral inoculation differed
between the L. monocytogenes strains, but in general no
significant (p > 0.05) difference in bacterial loads among
pregnant and non-pregnant animals were observed [223].
However, embryo, yolk sack and decidual tissue frequently
harbored high number of bacteria, and infection of decid-
ual tissues appeared to be correlated with increased mater-
nal mortality [223].
Many details about the mechanisms by which L. mono-
cytogenes crosses the placental barrier and causes abortion
or stillbirth remain yet to be fully understood. Abortion is
a common outcome of listeriosis in humans, monogastric
mammals as well as ruminants, regardless of the type of
placentation [23,55]. Ruminants, pigs and horses have an
epitheliochorial placenta. The placenta of carnivores is an
endotheliochorial placenta. Primates, rodents and lago-
morpha, on the contrary, share a hemochorial placenta,
characterized by direct contact between fetal chorion and
maternal capillaries. Importantly, fewer cellular layers
between fetal chorion and maternal capillaries generally
result in more efficient transfer of nutrients and other
macromolecules including immunoglobulins. The placen-
tas of humans and mice are both of discoidal type and
have been studied and compared extensively, primarily to
study physiological and pathological processes during
human pregnancy. Especially during the third trimester of
gestation, human and murine placentas share considerable
similarities in structure, function and likely also in the
embryonic origin of placental cells [224]. However, some
anatomical differences between the two species exist. For
instance, in the murine placenta the spaces that contain
the maternal capillaries appear considerably more maze-
like than in human placentas while the fetal capillaries
have a porous instead of continuous endothelium that
facilitates exchange of small molecules (see [224] for a
detailed comparison). Proteomic and transcriptomic com-
parison of microdissected human and murine placentas,
focusing on the regions of materno-fetal exchange (i.e., vil-
lous tree in humans and labyrinth in mice), revealed 7000
orthologous genes of which 70% were co-expressed in
both mice and humans [225].
In the placentas of women with listeriosis, as well as in
the placentas of naturally or experimentally inoculated
animals, L. monocytogenes can be detected in the intervil-
lous spaces, the villous core, and the trophoblast [23,24].
These observations, paired with the absence of bacteria
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placentas, led to the hypothesis that L. monocytogenes
infection occurs through the transplacental route [24].
L. monocytogenes is thought to cross the placental barrier
at the interface of syncytiotrophoblast and fetal blood ves-
sel [12]. On the contrary to observations in mice and gui-
nea pigs, crossing of the human placenta appears to be
both InlA and InlB dependent [12]. In vivo experiments in
pregnant gerbils demonstrated that intravenous infection
with 2 × 10
6 cfu L. monocytogenes EGD consistently led to
fetal infection, while EGD inlA, inlB and inlA/B deletion
mutants all showed significantly (p < 0.05) reduced placen-
tal invasion and fetal infection based on competitive
indexing [12]. However, competitive indexing results
appeared to vary somewhat among the deletion mutants
and all deletion mutants appeared able to invade placenta
and fetus, likely signifying the presence of alternate infec-
tion routes [12]. Surprisingly, in wild type mice and guinea
pigs, invasion of the placenta appears to be neither InlA
nor InlB dependent, but the placenta of E16PmEcad
knock-in mice that express humanized Ecad in all organs,
appears more than one order of magnitude more permis-
sive to L. monocytogenes E G Dt h a nt ot h ed e l e t i o n
mutants [12]. The exact mechanisms by which InlA and
InlB dependent entry pathways interact in the placenta are
currently unclear. Notably, cell-to-cell spread has also
been shown to play a key role in fetal infection, at least in
guinea pigs [53]. A variety of different infection pathways
therefore appear capable of potentially leading to fetal
infection, and species-specific differences likely impact
fetal infections in different species.
Studies in pregnant animals differ considerably in the
timing of inoculation relative to gestation, the length of
follow-up after inoculation, and the study endpoint. Non-
human primates and guinea pigs have received increasing
attention in recent years, even though the adequacy of the
guinea pig model has been critically re-evaluated since the
species-specificity of the InlB-MET interactions have been
elucidated [11,12]. Gerbils may represent promising
rodent models of pregnancy-associated listeriosis, but the
data available for this species are currently limited.
9.1 Non-human primates as models of pregnancy-
associated listeriosis
A non-human primate model of L. monocytogenes induced
stillbirth has been developed [14]. This animal model may
potentially be the most appropriate model for human dis-
ease due to the close phylogenetic relatedness between
humans and apes, but ethical, economic and practical con-
siderations have thus far limited the number of studies and
replicates available as well as the sample size. Stillbirth,
premature birth as well as normal birth were observed in
rhesus monkeys inoculated orally during the last trimester
of gestation with 10
2-10
10 cfu of L. monocytogenes strain
Scott A, with another serotype 1/2a strain, or with 4b
strains [13,14]. The inoculum was delivered in whipping
cream (i.e., 30% milk fat), “half-and-half” (i.e., 11% milk
fat) or skim milk (i.e., < 1% milk fat) - with the latter two
food vehicles abandoned after initial testing because infec-
tivity appeared to be the highest in whipping cream
[13,14]. The respective dose required to induce stillbirth in
50% of non-human primates has been estimated to fall in
the range of 10
6-10
8 cfu L. monocytogenes, averaged across
strains, gestation days and using whipping cream as food
vehicle [13]. Clinical symptoms were not reported in any
of the inoculated pregnant monkeys and L. monocytogenes
was not isolated from all aborted fetuses [13,14].
9.2 Guinea pigs as models of pregnancy- associated
listeriosis
Pregnant guinea pigs have repeatedly been used to model
listeriosis, using a variety of different endpoints of infec-
tion [53,206,208]. Similar to observations in non-pregnant
guinea pigs, pregnant guinea pigs appear to be relatively
resistant to L. monocytogenes. For instance, pregnant gui-
nea pigs inoculated with up to 10
8 cfu of a L. monocyto-
genes serotype 1/2a strain through the oral route were not
reported to exhibit clinical symptoms, even though 20 of
the 22 dams inoculated with 10
6 or more cfu harbored
L. monocytogenes in the liver and spleen [16]. Noticeably,
the occurrence of stillbirths appeared to be dose-depen-
dent [226]. On average, 11% (1/9), 30% (3/10) and 75%
(3/4) of the 23 dams inoculated with doses of 10
6,1 0
7 and
10
8 cfu aborted, and the average time interval between
inoculation and abortion decreased from 20 to 10 days as
the inoculation dose increased [227]. The occurrence of
apoptosis in the placentas of these guinea pigs also appears
to be dose-dependent [208]. The dose required to cause
stillbirth in 50% of guinea pigs has been approximated at
10
7 cfu using an L. monocytogenes serotype 1/2a strain
delivered orally in commercial heavy whipping cream [16].
Noticeably, mortality of fetuses in a given litter ranged
f r o m0t o9 5 %a n da p p e a r e dt ob ed o s e - d e p e n d e n t[ 1 6 ] .
Surprisingly, however, the level of bacterial invasion in the
maternal liver did not appear to be a reliable predictor of
fetal mortality [16].
Relatively high infectious doses seem to be needed to
cause fetoplacental infection in guinea pigs [206].
Bakardjiev et al., for instance, reported that 10
6 cfu of
L. monocytogenes strain 1043S had to be given intrave-
nously to cause maternal and fetoplacental infection
[206]. When guinea pigs were inoculated with 2 × 10
7
cfu, L. monocytogenes appeared to accumulate in the
placenta and placentas contained multifocal inflamma-
tory lesions in the labyrinth as well as surrounding the
maternal blood vessels [206]. Most, but not all fetuses of
a given dam became infected during challenge with high
doses [206]. In another study, pregnant guinea pigs
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nd to 3
rd trimester of
gestation in humans) were inoculated intravenously with
10
9 cfu L. monocytogenes 1043S and L. monocytogenes
was detected in the livers of all fetuses 24 h post inocu-
lation [53]. Clinical symptoms in the pregnant guinea
pigs, however, were not reported [53]. Notably, L. mono-
cytogenes strain - specific differences in the ability to
invade maternal, placental and fetal tissues of experi-
mentally inoculated guinea pigs after oral inoculation in
whipping cream have been described, indicating the
likely importance of L. monocytogenes strain-specific
properties for infection in pregnant as well as non-preg-
nant animals [228].
9.3 Other rodent models of pregnancy- associated
listeriosis
As discussed above and similar to the use of geriatric
mouse models to understand immunological responses
[20], mice have repeatedly been used to understand
immune responses to L. monocytogenes infection during
pregnancy (see for instance [229,230]). Pregnant BALB/c
mice, challenged through the intraperitoneal route with
10
5 cfu L. monocytogenes EGD, have also been used to
demonstrate a protective role of CpG oligodeoxynucleo-
tides (CpG ODN), short single-stranded synthetic DNA
molecules that contain CpG motives which stimulate
innate immune responses through TLR-9, on L. monocyto-
genes infection [231]. Pregnant mice appear to be consid-
erably more susceptible to infection after oral inoculation
than non-pregnant mice, but susceptibility in pregnant
mice also differs with L. monocytogenes strain [223]. Com-
parison of different mice strains, gestation days at inocula-
tion, and days of sacrifice identified BABL/c mice as the
most adequate strain and inoculation on gestation day 14
as the optimal timing [219]. Non-pregnant BALB/c mice
appeared to clear bacteria more rapidly after intravenous
inoculation with 2.5 × 10
4 cfu of L. monocytogenes EGD
than pregnant mice inoculated on varying days of gesta-
tion, with mean durations of infection equaling 7 and 14
days, respectively [232]. Clinical symptoms in the inocu-
lated dams were not reported [232].
Increased susceptibility during pregnancy has also been
demonstrated in rats after subcutaneous infection with a
L. monocytogenes serotype 4b strain, with LD50 values
equaling 10
8 and 10
9 cfu for pregnant and non-pregnant
rats, respectively [204]. Susceptibility appeared to be the
greatest on day 16 of gestation, while infection on gesta-
tion day 9 appeared to result in resorption of fetuses but
survival of the dams [204]. Gerbils have recently been
used as experimental models of infection and the data
appears somewhat promising, but so far the data available
on L. monocytogenes infection in this species is very scarce
[12]. Ultimately, it appears that the final verdict regarding
the most adequate model of L. monocytogenes infection
during pregnancy has to be postponed until the pathophy-
siology and immunology of L. monocytogenes infection
during pregnancy has been elucidated in sufficient detail
to permit comprehensive evaluation of the strengths and
limitations of different animal models. It seems for
instance that the intricate and interdependent roles of
InlA and InlB in the transgression of the placental barrier
have to be understood completely and that the nature of
alternate infection routes that appear to permit infection
in vivo has to be elucidated before a final, evidence-based
decision about the choice of animal models can be made.
10. Geriatric models of listeriosis
Elderly and immunosuppressed individuals are at a parti-
cularly high risk of acquiring listeriosis [55]. Animal mod-
els specific to these population subgroups have been
developed and geriatric models have occasionally been
used to study infections with L. monocytogenes, as well as
other pathogens such as Salmonella, Staphylococcus aur-
eus or Toxoplasma gondii [233-239] but such models are
very cost intensive and numerous questions about their
relevance for human disease remain [240]. In geriatric
patients as well as in aged laboratory animals, aging and
underlying diseases are often intricately linked [241]. Old
laboratory mice, for instance, are very commonly affected
by underlying conditions such as hepathopathies, glomer-
ulonephropathies, or neoplasies, and age-dependent
changes in cells, tissues and organs often begin to develop
before mice reach their median life expectancy [240]. Ani-
mal species differ in median life expectancy, in common
geriatric diseases and conditions, and for mice the aging
process appears to differ considerably among strains
[240,241]. The determination of age equivalencies between
humans and laboratory rodents is complicated by dynami-
cally changing age relationships over the course of life,
with one study quoting age equivalencies for 12, 45 and 70
year old humans as 1, 13 and 24 month old mice [241].
Clear definitions of geriatric models that are based on
judicious selection of animal species and strains, age group
and individual animals are therefore an indispensable pre-
requisite to permit meaningful inference for humans, but
for many animal species, only limited knowledge of geria-
tric processes is currently available.
The immunological and physiological changes that
determine the increased susceptibility of geriatric indivi-
duals to infection are only partially understood, but seem
to be predominantly associated with functional defects in
the lymphocyte-macrophage system [242]. T-cell mediated
immunity is decreased in aged individuals, probably pri-
marily due to decreasing numbers of naïve T cells, higher
expression of prostaglandin E2 by macrophages, and
intrinsic changes in naïve and memory T cells such as
decreased IL-2 secretion and T-cell receptor expression,
increased expression of suppressors of cytokine signaling
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cytic cells, including Kupfer cells, of geriatric individuals
also generally appear to be impaired in their endocytic
capacity [244]. Aged mice are more sensitive to LPS than
younger animals, manifested as decreased LD50 values and
increased expression of cytokines IL-1a,I L - 6 ,I L - 1 0a n d
TNF-a after LPS exposure [245]. Geriatric individuals
therefore seem to differ from middle-aged adults in
numerous ways. Importantly, nutritional factors such as
vitamin E have been shown to enhance T cell-mediated
functions in geriatric animals and humans, emphasizing
the complexity of modeling geriatric disease [243].
Several studies have reported an increased susceptibility
of geriatric animals to infection with L. monocytogenes
[246]. Patel, for instance, inoculated 8 to 12 week and 24
to 28 month old backcrossed (A/Tru × C57Bl/6) mice
with 10
3 to 10
4 cfu of L. monocytogenes strain EGD via the
intravenous route, and detected higher bacterial loads in
the liver and spleen of old mice [247]. In another study,
Patel [144] found 24 month old (A/Tru × C57Bl/6) back-
crossed mice inoculated with L. monocytogenes strain EGD
more susceptible to infection than 8 month old mice of
the same strain, with LD50 values equaling 1.6 × 10
5 and 4
×1 0
6, respectively. In transfusion experiments Patel deter-
mined that T-cells derived from geriatric (A/Tru × C57Bl/
6) backcrossed mice were 100 fold less efficient at protect-
ing naïve mice from infection with L. monocytogenes strain
EGD than T-cells derived from younger animals regardless
of the age of the recipient mouse, and geriatric mice
appeared to produce approximately 10 fold fewer protec-
tive T-cells than younger animals [236]. Aged mice of the
BALB/c strain were found to be increasingly susceptible to
infection with L. monocytogenes after intravenous infection
[233]. Notably, significant (p < 0.05) age-dependent differ-
ences after challenge with 10
5 cfu of L. monocytogenes
were detected in mice as young as 11 month of age when
compared to younger mice, but differences were consider-
ably more pronounced in 18 than 11 month old mice
[233]. Geriatric rats, 20 months of age, were more suscep-
tible to pulmonary disease after intratreacheal inoculation
with L. mononocytogenes strain 10403S than younger rats
2.5 months of age [234]. Notably, all geriatric rats died
within 6 days of intratracheal challenge with 5 × 10
5 cfu of
L. mononocytogenes strain 10403S, while 28% of younger
rats were still alive 7 days after challenge, even though
they succumbed to infection by day 8 post challenge [234].
Wu et al. [248] inoculated starved guinea pigs retired
from breeding colonies (weighing approx. 1000 g) and
starved younger guinea pigs (weighing 250-300 g) with
100 CFU of a L. monocytogenes serotype 4b strain via oral
gavage. Overall, 15% (i.e., 6/39) of geriatric animals and
8% (3/37) of younger animals developed infection based
on pathogen detection in the liver and spleen, but none of
the animals succumbed to infection, and only occasional
mild gastro-intestinal symptoms developed in any of the
animals [248]. Treatment with vitamin E appeared to have
a protective effect for both geriatric and younger animals
[248]. Similar results have also been described by Pang
et al. [21], who analyzed the impact of vitamin E on
L. monocytogenes infection in approximately 2-year-old
guinea pigs that had been retired from breeding colonies.
Bruce et al. [235] reported somewhat impaired clearance
of L. monocytogenes from the liver and spleen of vitamin D
receptor knock-out mice compared to wild type mice of
strain C57BL/6, again emphasizing the potential impact of
nutritional factors.
Notably, on the contrary to the results presented above,
some studies have reported an increased resistance of
older mice to L. monocytogenes infection. Lovik et al.
[237], for instance, reported an increased mean time to
death (i.e., 6.7 vs. 4.7 days) and a decreased LD50 value
(6.4 × 10
5 to 1.8 × 10
6 vs. 1.2 × 10
5 to 8 × 10
5)f o r2 2
to 30 months compared to 11 to 16 week old (A/Tru ×
C57Bl/6) backcrossed mice inoculated intravenously
with L. monocytogenes strain EGD. Gervais et al. [249] stu-
died the susceptibility of 18 to 22 month old (A/J ×
C57BL/6 J) backcrossed mice to L. monocytogenes infec-
tion and reported diminished subcutaneous inflammatory
responses compared to younger animals. Surprisingly,
macrophages and Kupffer cells isolated from the older
mice exhibited increased in-vitro antilisterial characteris-
tics compared to cells isolated from younger mice, again
indicating increased resistance of older mice to L. monocy-
togenes infection [249]. Several fundamental questions
about the relevance of current geriatric models for the
study of listeriosis therefore clearly remain.
11. Conclusions and lessons learned
In conclusion, the pathophysiology and immunology of
L. monocytogenes infection is increasingly being elucidated,
but several key components remain to be explained that
may ultimately revolutionize our thinking about the ade-
quacy of animal models for modeling disease in humans.
Species-specific differences in Ecad and MET have been
identified, but their definitive roles in the pathophysiology
of listeriosis remain yet to be determined. As discussed
above, rabbits and guinea pigs both appear to harbor MET
receptors that cannot be activated by InlB, but rabbits
seem considerably more susceptible to infection than gui-
nea pigs and histopathological lesions in non-pregnant
guinea pigs often appear localized in the myocardium.
Murine and rat Ecad both carry the Pro16Glu mutation,
while guinea pigs, rabbits and chickens do not. Yet, rats
and guinea pigs appear considerably more resistant to
L. monocytogenes infection than most mouse strains. Many
questions regarding susceptibility differences among
mouse strains, age groups, and L. monocytogenes strains
also so far remain unresolved.
Hoelzer et al. Veterinary Research 2012, 43:18
http://www.veterinaryresearch.org/content/43/1/18
Page 20 of 27Mouse models have been widely used for many decades
and much of the currently available data on pathophy-
siology and immunology of L. monocytogenes infections
has been generated in mice. However, recent findings
cast doubt on the adequacy of this animal model, at least
for certain aspects of infection. Novel, perhaps more
appropriate animal models are currently being evaluated,
but considerably more data has to be collected before the
adequacy of these models can be evaluated comprehen-
sively. Ideal animal models are biologically relevant, reli-
able, cost-effective, and sustain strict scientific and
ethical scrutiny. Currently, no single animal model
appears to fully meet all of these criteria and it appears
that the most adequate animal model of human disease
may have to be selected based on the specific aspect of
infection to be studied, at least until more adequate ani-
mal models have been validated. A variety of animal spe-
cies are susceptible to naturally occurring listeriosis, but
the degree of susceptibility and the clinical manifestations
appear to differ by species, physiological state, age group
and L. monocytogenes strain. Perhaps with the exception
of rhombencephalitis, invasive listeriosis appears to be an
infection of immuno-compromised individuals - the
young, the old, the pregnant and those with immune dis-
orders appear to be at risk of developing disease. To date,
it has been impossible to reliably reproduce the full spec-
trum of clinical disease in adult animals through experi-
mental inoculation using relevant inoculation routes,
regardless of the animal species, even when geriatric ani-
mals were used, multiple doses were given, or immune
suppression was experimentally evoked in the animals. It
thus appears that a more comprehensive understanding
of the immunological determinants of susceptibility, as
well as of the pathophysiology of infection, is needed
before fully satisfactory animal models can be devised.
11.1 Consequences for modeling L. monocytogenes dose-
response
Animal models have repeatedly been used to infer infec-
tious or lethal doses for humans, estimates to be used in
risk assessments or policy decisions. However, given the
extraordinary variability in dose-response among animal
species, the impact of L. monocytogenes strain-specific dif-
ferences, and the numerous remaining questions about
pathophysiology and immunology, it appears unclear
which if any animal model is the most adequate to model
human dose-response. Non-human primates may be the
most relevant animal model for human dose-response, but
so far only a limited number of experiments, restricted,
due to ethical and practical considerations, to a small
number of pregnant animals, L. monocytogenes strains,
food matrices and only using application of a single dose
(as opposed to multiple dosing), have been conducted.
The available data with this animal model will only
capture a limited amount of variability in dose-response
relationships. Moreover, non-human primate dose-
response models are currently not available for elderly,
immune-compromised or neonatal (i.e., late-onset listerio-
sis) cases, which together constitute a considerable frac-
tion of human cases. In the absence of other data, data
collected in mice and other animal species may possibly
be substituted to infer measures of variability among L.
monocytogenes strains, species, genetic backgrounds and
immune conditions and to understand basic properties of
the immune responses elicited in response to infection.
However, such data has to be diligently tied to epidemiolo-
gic data collected among humans, results have to be inter-
preted in the light of emerging data on species-specific
differences, and the limitations of such inferences have to
be clearly acknowledged. Comparative studies, combining
evidence collected in more than one susceptible animal
species such as non-human primates or gerbils, may allow
for more meaningful inference about human dose-
response. However, considerable differences in experimen-
tal design, disease outcome of interest, and genetic, phy-
siological and immunological make-up of (often inbred)
laboratory animals complicate comparisons across studies.
Weight-of-evidence approaches may prove suitable to elu-
cidate the impact of certain factors on dose response, such
as for instance strain variability among mice. However, in
the absence of a clear understanding of pathophysiology
and immunology, weight-of evidence approaches may
prove confusing or even misleading. The potential impact
of various experimental conditions, such as the food
matrix used for inoculation, the potential effect of antacids
or starvation, the effect of repeated dosing - with short or
long time intervals between doses -, the potential effect of
microscopic lesions inflicted for instance during intragas-
tric inoculation, and the true impact of L. monocytogenes
strain - specific characteristics in different species or phy-
siological stages, remain yet to be determined. However,
such data will be vital to adequately evaluate the biological
relevance of a given animal model for human disease.
In summary, much has been learned about L. monocy-
togenes since its first isolation from naturally infected
rodents, but truly suitable animal models of infection
are so far still missing, and many uncertainties remain
when animal models are employed to model human
infection.
Endnotes
aE16PmEcad mice were generated by crossing germline
chimeras (i.e., chimeras between: i) transgenic CK35
embryonic stem (ES) cells - an ES cell line derived from
murine strain 129/Sv [250]- that were genetically modified
to express murine E-cadherin with the E16P mutation (i.e.,
‘humanized’ E-cadherin), and ii) C57BL/6 blastocystes)
with mice transgenic for the Cre site-specific recombinase
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Page 21 of 27that were generated in the BALB/c × C57B1/B6 back-
ground [12,251].
bi.e., HeLa (origin: human cervical adenocarcinoma),
Nme (derived from NMuMG cells, an immortalized line
of mouse mammary epithelial cells [180,184]), RK13
(origin: rabbit kidney cells), GPC16 (origin: guinea pig
colorectal adenocarcinoma), 104 (origin: guinea pig fetal
fibroblast) and JH4 (origin: guinea pig lung fibroblast)
cells.
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